Your Podsite trial is ending soon. Put the final touches on it with our tips on how to make a great podcast website.

Claim your custom domain name todayClaim your domain

S9: #088: Advancing Digital Medicine: Stronger, Smarter and Faster

32 minutes

Overcoming challenges and accelerating change with Jen Goldsack of the (new!) Digital Medicine Society

The use of the term ‘digital health' is continuing to grow, with new subsets of products and services being grouped within it: digital doctor’s visits, digital clinical trials, digital therapeutics, and digital medicine – these are just some of the terms that have burst onto the scene.

In this episode, we’re diving into one of the terms in the digital health lexicon: ‘digital medicine'. We explore what digital medicine is, how it is positioned along with digital therapeutics and digital health, and explore what’s needed to make the field of digital medicine stronger, smarter and faster.

My guest is Jen Goldsack, the Interim Executive Director of the Digital Medicine Society, a new organization that’s just been launched. Jen has a background in clinical trials, outcomes research, and innovation, and she holds masters degrees from the University of Oxford in England, the University of Pennsylvania, and an MBA from George Washington University.

Jen is also a retired athlete; she is a Pan American Games Champion, Olympian and World Championship silver medalist. She’s a dual-national with both British and American citizenship, and currently resides in Florida. Jen also shares her journey from being an elite athlete to the elite field of healthcare, and her motivation for making a real difference to both individuals and populations.


Episode Download:

Get a Copy of the Notes About the Digital Medicine Society


Today's Topics:

  • Jen's career as a professional athlete and how she applied those experiences and her competitive nature towards a career in healthcare
  • The definition of ‘digital medicine' and the role of hardware, software, evidence and pharma
  • The current participating companies, stakeholders and products who currently inside the Digital Medicine space
  • The stakeholders in Digital Medicine and the roles and opportunities for patients
  • The three primary challenges that the industry needs to overcome to accelerate development and adoption of digital medicine
  • The mission of the Digital Medicine Society and how they will help overcome the challenges and serve their stakeholders


Links and Resources Mentioned:


Digital Health Today is made possible by the support of our sponsors. Thank you!

Learn more about your ad choices. Visit megaphone.fm/adchoices

More episodes from Digital Health Today 360 with Dan Kendall

S11: #110 Introducing the Host of the New Asia Pacific Edition: Tony Estrella

"In this episode, I'm excited to introduce you to yet another outstanding health innovation leader who is hosting another new show on Digital Health Today. His degrees are in engineering …

S11: #109 Introducing the Host of the new Digital Therapeutics Podcast: Eugene Borukhovich

In this episode, I have the pleasure of introducing you to one of the health sectors leading innovators, and probably one of the best known and, dare I say it, most loved, leaders I’ve had …

Coffee Talk: How Corporations Adapt in the Face of New Challenges

In this episode I welcome two executives from Bayer G4A. Bayer G4A has been a longtime sponsor of Digital Health Today. I caught up with Dominick Kennerson, Global Head G4A, Digital Health …

Coffee Talk: How Digital Health Startups Respond and Thrive in a Global Pandemic

Imagine this: You’re the founder of a digital health startup. You’ve been carefully selected and invited to participate in a brand new accelerator in …

S11: #108 - What the Clearance of Akili's EndeavorRX Means for the Company, Users and the Industry

If you’ve been tuned into nearly any news channel recently, you’ve probably seen the announcement by Akili about the clearance they announced on June 15 for their product EndeavorRX. It is …

Coffee Talk: How Innovative Companies can Partner with a Global Pharma Brand

For this special Coffee Talk, I invited Sophie Park, Chief Strategist for Bayer G4A Partnerships to discuss the opportunities for innovative companies to grow and partner with a global …

How you can listen to this podcast

You can listen to episodes right here on the website, or if you prefer, in a podcast app. Listening in an app makes it easier to keep track of what you’ve already heard, listen without using your data plan and many other conveniences.

Recommended apps
Start listening to S11: #110 Introducing the Host of the New Asia Pacific Edition: Tony Estrella
28:29
Start listening to S11: #110 Introducing the Host of the New Asia Pacific Edition: Tony Estrella
28:29